ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 20, 2008 | $1,320,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Feb 13, 2009 | $1,140,000 | Yes |
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Discussion of international trade issues, including free-trade agreements, with Members and Staff-US House/US Senate
| Lobbyist | Covered position, as disclosed |
|---|---|
| KENNETH LEVINSON | Leg. Assistant to Sen. Jay Rockefeller 1991-97 |
Taxation/Internal Revenue Code TAX
Discussion of tax issues, including extension of the Research and Development Tax Credit, and bilateral US-UK tax issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| KENNETH LEVINSON | Leg. Assistant to Sen. Jay Rockefeller 1991-97 |
Copyright/Patent/Trademark CPT
S.1145-The Patent Reform Act of 2007, Potential implications of pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries Discussions regarding intellectual property issues with Members and Staff-US House Discussions regarding authorized generics legislation-US House/US Senate Discussions regarding Patent Settlements (reverse payments) Legislation-US House/US Senate
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BUCKLEY | — |
| KENNETH LEVINSON | Leg. Assistant to Sen. Jay Rockefeller 1991-97 |
| RICHARD WAYNE OLSON | — |
| BRADLEY ALLEN ROSSIN | — |
Health Issues HCR
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BUCKLEY | — |
| MICHAEL DRAINE | — |
| ANDRES IZQUIERDO | — |
| AMANDA GRASHOF MOTT | — |
| RICHARD WAYNE OLSON | — |
| WAYNE PALMER | — |
Medicare/Medicaid MMM
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BUCKLEY | — |
| MICHAEL DRAINE | — |
| AMANDA GRASHOF MOTT | — |
| RICHARD WAYNE OLSON | — |
| WAYNE PALMER | — |
| BRADLEY ALLEN ROSSIN | — |
Consumer Issues/Safety/Products CSP
Discussions regarding protection of patient safety from the commercial importation of prescription medications Discussions regarding impact and safety issues surrounding the presence of pharmaceuticals in the environment - No specific legislation HR 5839-The Safeguarding America's Pharmaceuticals Act-US House Import Safety Discussion Draft legislation-US House/US Senate
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BUCKLEY | — |
| MICHAEL DRAINE | — |
| RICHARD WAYNE OLSON | — |
| BRADLEY ALLEN ROSSIN | — |
Pharmacy PHA
Discussions regarding FDA Appropriations Discussions regarding e-Prescribing Discussions regarding implementation of PDUFA IV/FDAAA Direct-to-Consumer Advertisement User Fee Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BUCKLEY | — |
| RICHARD WAYNE OLSON | — |
| WAYNE PALMER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.